看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。) s; Y" [! t, ^! J: n+ I
) n: @8 o% h6 ?5 P
3 q0 _/ K# |2 N
Currently available feasibility data for possible combination strategies. * s# r/ P! S8 N! n" O
————————————————————————————————
' M2 o* y' R( ?: ^' E3 A zCombination Feasibility according to preliminary data
8 H0 Z7 K: R) W: p. U/ I0 W9 w5 n/ U—————————————————————————————————— B( H! L+ g j M# t2 d$ p% D
Bevacizumab + sorafenib Yes, reduced dose
8 ^. O4 l3 d9 PBevacizumab + sunitinib† No
6 c0 {8 r& j& e, g( \1 r1 GBevacizumab + temsirolimus Yes 9 ?, R& D1 J4 a z
Bevacizumab + everolimus Yes
& y! ]# v0 i$ Z2 \, V1 |Sorafenib + sunitinib ? : T0 o' L3 W7 U3 h
Sorafenib + temsirolimus Yes, reduced dose
* N e) r4 a' `Sorafenib + everolimus Yes, reduced dose
, |+ }8 ^4 L0 e' h; T- a% DSunitinib + temsirolimus† No
1 N8 c; L' ^! l: e( Q" ZSunitinib + everolimus ? ' l: B$ x7 S3 n' Q" [5 ?# Z+ e
Temsirolimus + everolimus ?
3 p- t H- O6 i3 O————————————————————# I# W$ l% w7 v/ N2 T" ?5 \
†Led to US FDA warning.* k( B5 u6 [& i
?: As yet unattempted combination.
/ s0 {( W$ k$ R! Z& e* [ |